Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist - PubMed (original) (raw)
. 2001 Mar 1;61(5):2232-8.
M Malkowski, Z Yin, E Tanghetti, B Yaremko, T Nechuta, J Varner, M Liu, E M Smith, B Neustadt, M Presta, L Armstrong
Affiliations
- PMID: 11280792
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist
C C Kumar et al. Cancer Res. 2001.
Abstract
New blood vessel formation is essential for tumor growth and metastatic spread. Integrins alpha(v)beta3 and alpha(v)beta5 are arginine-glycine-aspartic acid-dependent adhesion receptors that play a critical role in angiogenesis. Hence, selective dual alpha(v)beta3 and alpha(v)beta5 antagonists may represent a novel class of angiogenesis and tumor-growth inhibitors. Here, an arginine-glycine-aspartic acid-based peptidomimetic library was screened to identify alpha(v)beta3 antagonists. Selected compounds were then modified to generate potent and selective dual inhibitors of alpha(v)beta3 and alpha(v)beta5 receptors. One of these compounds, SCH 221153, inhibited the binding of echistatin to alpha(v)beta3 (IC50 = 3.2 nM) and alpha(v)beta5 (IC50 = 1.7 nM) with similar potency. Its IC50 values for related alpha(IIb)beta3 and alpha5beta1 receptors were 1294 nM and 421 nM, respectively, indicating that SCH 221153 is highly selective for alpha(v)beta3 and alpha(v)beta5 receptors. In cell-based assays, SCH 221153 inhibited the binding of echistatin to alpha(v)beta3- and alpha(v)beta5-expressing 293 cells and blocked the adhesion of endothelial cells to immobilized vitronectin and fibroblast growth factor 2 (FGF2). SCH 221153, but not the inactive analogue SCH 216687, was effective in inhibiting FGF2 and vascular endothelial growth factor-induced endothelial cell proliferation in vitro with an IC50 equal to 3-10 microM. Angiogenesis induced by FGF2 in the chick chorioallantoic membrane assay was also inhibited by SCH 221153. Finally, SCH 221153 exerted a significant inhibition on tumor growth induced by intradermal or s.c. injection of human melanoma LOX cells in severe combined immunodeficient mice.
Similar articles
- Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L, Riccioni T, Marcellini M, Vesci L, Chiarucci I, Efrati D, Potenza D, Scolastico C, Manzoni L, Lombardo K, Stasi MA, Orlandi A, Ciucci A, Nico B, Ribatti D, Giannini G, Presta M, Carminati P, Pisano C. Belvisi L, et al. Mol Cancer Ther. 2005 Nov;4(11):1670-80. doi: 10.1158/1535-7163.MCT-05-0120. Mol Cancer Ther. 2005. PMID: 16275988 - A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP, Meyer DM, Pegg JA, Engleman VW, Nickols MA, Settle SL, Westlin WF, Ruminski PG, Nickols GA. Carron CP, et al. Cancer Res. 1998 May 1;58(9):1930-5. Cancer Res. 1998. PMID: 9581835 - Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A. Hagedorn M, et al. Cancer Res. 2002 Dec 1;62(23):6884-90. Cancer Res. 2002. PMID: 12460903 - Integrins as targets of angiogenesis inhibition.
Westlin WF. Westlin WF. Cancer J. 2001 Nov-Dec;7 Suppl 3:S139-43. Cancer J. 2001. PMID: 11779085 Review. - Small molecule antagonists of integrin receptors.
Perdih A, Dolenc MS. Perdih A, et al. Curr Med Chem. 2010;17(22):2371-92. doi: 10.2174/092986710791698558. Curr Med Chem. 2010. PMID: 20491638 Review.
Cited by
- α5β1 integrin induces the expression of noncartilaginous procollagen gene expression in articular chondrocytes cultured in monolayers.
Tanaka N, Ikeda Y, Yamaguchi T, Furukawa H, Mitomi H, Nakagawa T, Tohma S, Fukui N. Tanaka N, et al. Arthritis Res Ther. 2013 Sep 19;15(5):R127. doi: 10.1186/ar4307. Arthritis Res Ther. 2013. PMID: 24286194 Free PMC article. - The Roles of Integrin α5β1 in Human Cancer.
Hou J, Yan D, Liu Y, Huang P, Cui H. Hou J, et al. Onco Targets Ther. 2020 Dec 31;13:13329-13344. doi: 10.2147/OTT.S273803. eCollection 2020. Onco Targets Ther. 2020. PMID: 33408483 Free PMC article. Review. - The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.
Ribatti D. Ribatti D. Pharmaceuticals (Basel). 2010 Mar 8;3(3):482-513. doi: 10.3390/ph3030482. Pharmaceuticals (Basel). 2010. PMID: 27713265 Free PMC article. Review. - Shedding New Light on The Role of ανβ3 and α5β1 Integrins in Rheumatoid Arthritis.
Morshed A, Abbas AB, Hu J, Xu H. Morshed A, et al. Molecules. 2019 Apr 18;24(8):1537. doi: 10.3390/molecules24081537. Molecules. 2019. PMID: 31003546 Free PMC article. Review. - The Role of Snake Venom Disintegrins in Angiogenesis.
Clissa PB, Della-Casa MS, Zychar BC, Sanabani SS. Clissa PB, et al. Toxins (Basel). 2024 Mar 1;16(3):127. doi: 10.3390/toxins16030127. Toxins (Basel). 2024. PMID: 38535794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous